Northstar Group Inc. Sells 100 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Northstar Group Inc. trimmed its position in iShares Biotechnology ETF (NASDAQ:IBB) by 4.5% in the 4th quarter, Holdings Channel.com reports. The fund owned 2,118 shares of the financial services provider’s stock after selling 100 shares during the quarter. Northstar Group Inc.’s holdings in iShares Biotechnology ETF were worth $280,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. BNP Paribas Financial Markets boosted its position in shares of iShares Biotechnology ETF by 29.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after purchasing an additional 538,899 shares in the last quarter. Commerce Bank raised its stake in iShares Biotechnology ETF by 1.8% in the third quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock valued at $108,234,000 after buying an additional 12,921 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in iShares Biotechnology ETF by 32.9% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after acquiring an additional 164,000 shares in the last quarter. Main Management ETF Advisors LLC grew its position in iShares Biotechnology ETF by 2.5% during the 3rd quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock worth $86,395,000 after purchasing an additional 14,535 shares during the last quarter. Finally, Aprio Wealth Management LLC acquired a new position in iShares Biotechnology ETF during the 4th quarter valued at approximately $18,476,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 2.1 %

NASDAQ:IBB opened at $137.67 on Friday. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57. The firm has a fifty day simple moving average of $136.22 and a 200-day simple moving average of $141.41.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.